Form 4 for BCDA BioCardia, Inc.
Accepted 2024-09-05 00:00:00 ET · period of report 2024-09-03 · accession 0001437749-24-028509 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-05 | 2024-09-03 | BCDA | Altman Peter | Pres, CEO, Dir | A - Grant | $3.00 | +41.7K | 81.4K | +105% | +$125.0K |
| D | 2024-09-05 | 2024-09-03 | BCDA | Altman Peter | Pres, CEO, Dir | A - Grant | — | +41.7K | 41.7K | New | — |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-03 | A | A | 41,666 | $3.00 | 81,411 | D | — | — | (F1) These shares were purchased from the Issuer in a public offering that closed on September 3, 2024, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. |
| 2 | Derivative | Warrant (right to buy) | 2024-09-03 | A | A | 41,666 | — | 41,666 | D | $3.00 · 2024-09-03 to 2029-09-03 | 41,666 Common Stock | (F1) These shares were purchased from the Issuer in a public offering that closed on September 3, 2024, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. |